Skip to main content

FDA recall, , Moderate risk

Thermo Fisher Diagnostics Neisseria Meningitidis Gp C Tests

Neisseria meningitidis Gp C 2ml/VL is not performing to IFU criteria, not positive to ATCC13102 within 60 seconds.

What happened

Remel Europe Ltd., based in Dartford, United Kingdom, began a recall on July 17, 2026, of Thermo Fisher Diagnostics Neisseria meningitidis Gp C 2ml/VL, Product Number R30166901, an invitro diagnostics. The agency stated that certain lots are not performing to IFU criteria, not positive to ATCC13102 within 60 seconds. The recall involves 26 units and was added to the FDA's Enforcement Report on August 7, 2026, with distribution nationwide in the US.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

Match the UDI-DI and lot code listed under your product.

A UDI-DI is the device identifier printed with the barcode on the device label.

  1. Thermo Fisher Diagnostics Neisseria meningitidis Gp C 2ml/VL, Product Number R30166901; invitro diagnostics

    UDI-DI
    • 05056080501161
    Lot code
    • 6214791

Recall details

Company began the recall
Sold in

US Nationwide distribution.

Company
Remel Europe Ltd.Dartford, United Kingdom
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
99450
Recall number
Z-2927-2026
Quantity recalled
26 units

All recalls from Remel Europe Ltd.

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. Listed on Recall Canary

  4. In FDA's weekly enforcement report

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 3, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)